MEMORANDUM ORDER
THYNGE, United States Magistrate Judge. ■
Currently before the court is defendant Ventana Medical Systems, Inc.’s (“Venta
na”) motion to dismiss Count IV of Digene Corporation’s (“Digene”) Second Amended Complaint (“Count IV”).
For the reasons discussed below, Ventana’s motion is granted.
BACKGROUND
On November 19, 2001 Digene filed a complaint against Ventana for willful infringement of United States Patent Nos. 4,849,331 (“the ’331 patent”) and 4,849,332 (“the ’332 patent”) in conjunction with the development, manufacture, marketing, sales, and offers for sale of its INFORM® HPV High Risk Probe and in its INFORM® HPV Low Risk Probe Products.
Digene further alleged that Ventana willfully induced others to infringe the patents-in-suit.
In the initial complaint, Di-gene sought, among other things, damages for Ventana’s past infringement, enhanced damages, and attorneys’ fees for Ventana’s willful infringement, and an injunction against Ventana’s continued infringement.
On February 2, 2002, Ventana answered the complaint, denying infringement and raising several defenses, including the affirmative defense that its allegedly infringing activities are licensed under the ’332 patent.
On September 23, 2002, Ventana and Beckman Coulter, Inc. (“Beckman”) executed an Asset Purchase Agreement (the “2002 APA”), which provided that Ventana would purchase Beckman’s entire right, title and interest in certain assets, including rights under a 1991 sublicense between Instituí Pasteur (“IP”) and Beckman.
On October 18, 2002, Digene moved for leave to file an Amended Complaint,
which the court granted on December 10, 2002.
On December 13, 2002, Digene filed its Amended Complaint, adding Beckman as a defendant and additional claims, including civil conspiracy.
On December 27, 2002, Ventana filed a motion to compel arbitration, to the stay proceedings, and to dismiss the conspiracy claim in the Amended Complaint.
On January 28, 2003, Digene moved for leave to file a Second Amended Complaint (“SAC”).
Leave was granted by the court,
and the SAC was deemed filed on March 5, 2003.
Count IV of the SAC asserts a claim for civil conspiracy.
On May 7, 2004, the court ordered Di-gene and Beckman to arbitration and stayed this case pending the outcome of
that arbitration.
Arbitration took place during March 2006 and the arbitration panel issued its award on July 27, 2006.
The court lifted the stay of these proceedings on August 15, 2006
and on August 29, 2006, Ventana filed its motion to dismiss the civil conspiracy claim, Count IV, of the SAC.
'
DISCUSSION
In reviewing a motion to dismiss under Rule 12(b)(6), the court must assume the truth of all well pleaded factual allegations set forth in the complaint, and must construe them in the light most favorable to the non-moving party.
“While a court will accept well-plead allegations as true for the purposes of the motion, it will not accept unsupported conclusions, unwarranted inferences, or sweeping legal conclusions cast in the form of factual allegation.”
Under Delaware law, civil conspiracy requires: “(1) A confederation or combination of two or more persons; (2) An unlawful act done in furtherance of the conspiracy; and (3) Actual damage.”
“Civil conspiracy is not an independent cause of action in Delaware, but requires an underlying wrong which would be actionable absent the conspiracy.”
Ventana argues that Count IV must be dismissed. Ventana contends that Digene only pleads two conspiratorial acts as part of the civil conspiracy claim: conspiracy to commit patent infringement; and conspiracy to evade its discovery obligations. Ventana argues that neither of these alleged conspiratorial acts can support Digene’s civil conspiracy claim as a matter of law.
First, Ventana argues that conspiracy to commit patent fraud cannot support Di-gene’s civil conspiracy claim because it is preempted by federal patent law and, therefore, fails to state a viable claim. Second, Ventana argues that alleged evasion of discovery obligations under the Federal Rules of Civil Procedure cannot create a private cause of action and, therefore, likewise fails to state a viable claim.
Digene counters that it “pleaded all the requisite elements of a civil conspiracy claim under Delaware law ... that two actors, Ventana and Beckman, conspired for the unlawful purpose of interfering with Digene’s business opportunities, and that Digene was monetarily injured as a result.”
Digene argues that accepting those allegations as true establishes a civil conspiracy claim under Delaware law. Di-
gene further argues that, “to the extent Digene’s civil conspiracy claim is based on underlying allegations of patent infringement, it is not clear that such a claim is preempted by federal law.”
Digene maintains that “the U.S. Court of Appeals for the Federal Circuit has recognized a claim for civil conspiracy to commit patent infringement.”
Finally, Digene contends that Ventana misreads its civil conspiracy count as an attempt to sanction Ventana for discovery abuses. Digene avers that its allegations that Ventana improperly concealed various information “bolsters its conspiracy claim in that it is further evidence of the conspiracy between Ventana and Beckman to hide information regarding the fraudulent Ventana/Beckman transaction from Digene and deprive or at least delay Digene’s ability to challenge that transaction, thereby interfering with Digene’s business opportunities.”
In its entirety, Count IV of the SAC recites:
Free access — add to your briefcase to read the full text and ask questions with AI
MEMORANDUM ORDER
THYNGE, United States Magistrate Judge. ■
Currently before the court is defendant Ventana Medical Systems, Inc.’s (“Venta
na”) motion to dismiss Count IV of Digene Corporation’s (“Digene”) Second Amended Complaint (“Count IV”).
For the reasons discussed below, Ventana’s motion is granted.
BACKGROUND
On November 19, 2001 Digene filed a complaint against Ventana for willful infringement of United States Patent Nos. 4,849,331 (“the ’331 patent”) and 4,849,332 (“the ’332 patent”) in conjunction with the development, manufacture, marketing, sales, and offers for sale of its INFORM® HPV High Risk Probe and in its INFORM® HPV Low Risk Probe Products.
Digene further alleged that Ventana willfully induced others to infringe the patents-in-suit.
In the initial complaint, Di-gene sought, among other things, damages for Ventana’s past infringement, enhanced damages, and attorneys’ fees for Ventana’s willful infringement, and an injunction against Ventana’s continued infringement.
On February 2, 2002, Ventana answered the complaint, denying infringement and raising several defenses, including the affirmative defense that its allegedly infringing activities are licensed under the ’332 patent.
On September 23, 2002, Ventana and Beckman Coulter, Inc. (“Beckman”) executed an Asset Purchase Agreement (the “2002 APA”), which provided that Ventana would purchase Beckman’s entire right, title and interest in certain assets, including rights under a 1991 sublicense between Instituí Pasteur (“IP”) and Beckman.
On October 18, 2002, Digene moved for leave to file an Amended Complaint,
which the court granted on December 10, 2002.
On December 13, 2002, Digene filed its Amended Complaint, adding Beckman as a defendant and additional claims, including civil conspiracy.
On December 27, 2002, Ventana filed a motion to compel arbitration, to the stay proceedings, and to dismiss the conspiracy claim in the Amended Complaint.
On January 28, 2003, Digene moved for leave to file a Second Amended Complaint (“SAC”).
Leave was granted by the court,
and the SAC was deemed filed on March 5, 2003.
Count IV of the SAC asserts a claim for civil conspiracy.
On May 7, 2004, the court ordered Di-gene and Beckman to arbitration and stayed this case pending the outcome of
that arbitration.
Arbitration took place during March 2006 and the arbitration panel issued its award on July 27, 2006.
The court lifted the stay of these proceedings on August 15, 2006
and on August 29, 2006, Ventana filed its motion to dismiss the civil conspiracy claim, Count IV, of the SAC.
'
DISCUSSION
In reviewing a motion to dismiss under Rule 12(b)(6), the court must assume the truth of all well pleaded factual allegations set forth in the complaint, and must construe them in the light most favorable to the non-moving party.
“While a court will accept well-plead allegations as true for the purposes of the motion, it will not accept unsupported conclusions, unwarranted inferences, or sweeping legal conclusions cast in the form of factual allegation.”
Under Delaware law, civil conspiracy requires: “(1) A confederation or combination of two or more persons; (2) An unlawful act done in furtherance of the conspiracy; and (3) Actual damage.”
“Civil conspiracy is not an independent cause of action in Delaware, but requires an underlying wrong which would be actionable absent the conspiracy.”
Ventana argues that Count IV must be dismissed. Ventana contends that Digene only pleads two conspiratorial acts as part of the civil conspiracy claim: conspiracy to commit patent infringement; and conspiracy to evade its discovery obligations. Ventana argues that neither of these alleged conspiratorial acts can support Digene’s civil conspiracy claim as a matter of law.
First, Ventana argues that conspiracy to commit patent fraud cannot support Di-gene’s civil conspiracy claim because it is preempted by federal patent law and, therefore, fails to state a viable claim. Second, Ventana argues that alleged evasion of discovery obligations under the Federal Rules of Civil Procedure cannot create a private cause of action and, therefore, likewise fails to state a viable claim.
Digene counters that it “pleaded all the requisite elements of a civil conspiracy claim under Delaware law ... that two actors, Ventana and Beckman, conspired for the unlawful purpose of interfering with Digene’s business opportunities, and that Digene was monetarily injured as a result.”
Digene argues that accepting those allegations as true establishes a civil conspiracy claim under Delaware law. Di-
gene further argues that, “to the extent Digene’s civil conspiracy claim is based on underlying allegations of patent infringement, it is not clear that such a claim is preempted by federal law.”
Digene maintains that “the U.S. Court of Appeals for the Federal Circuit has recognized a claim for civil conspiracy to commit patent infringement.”
Finally, Digene contends that Ventana misreads its civil conspiracy count as an attempt to sanction Ventana for discovery abuses. Digene avers that its allegations that Ventana improperly concealed various information “bolsters its conspiracy claim in that it is further evidence of the conspiracy between Ventana and Beckman to hide information regarding the fraudulent Ventana/Beckman transaction from Digene and deprive or at least delay Digene’s ability to challenge that transaction, thereby interfering with Digene’s business opportunities.”
In its entirety, Count IV of the SAC recites:
65. The foregoing allegations of this amended complaint are incorporated by reference.
66. Ventana and Beckman have combined and conspired for an unlawful purpose,
ie., patent infringement and inducement to infringe
the ’332 and ’331 patents and to
evade their discovery obligations,
with the intent to injure Digene.
67.As a direct and proximate result of the civil conspiracy, Digene has been injured by Ventana and Beck-man in an amount to be proven at trial.
Digene argues that the SAC “identifies some specific grievances in its civil conspiracy count, but it also specifically incorporates [in paragraph 65] the allegations that it pleaded earlier in the Second Amended Complaint. Namely, that Beck-man and Ventana tortiously interfered with Digene’s business opportunities in conjunction with the ’332 and ’331 patents.”
Digene cites
Mopex, Inc. v. Chicago Stock Exchange, Inc.
where the court denied a motion to dismiss a civil conspiracy claim based on the claim of tortious interference with business expectancy, as support for this argument.
In
Mopex,
plaintiffs’ complaint included one count alleging patent infringement and three counts alleging civil conspiracy to commit patent infringement. That complaint also included separate counts alleging tortious interference with business expectancy, as well as, civil conspiracy to commit tortious interference.
Defendants moved to dismiss the tortious interference claim and each of the civil conspiracy claims, but
only
argued preemption with regard to the counts alleging civil conspiracy to commit patent infringement.
After extensive analysis of federal
law preemption of state law,
the court determined that plaintiffs’ Illinois civil conspiracy claims based upon patent infringement liability were preempted by conflict with the patent laws.
The
Mopex
court held that plaintiffs sufficiently pled their claims of tortious interference and civil conspiracy to commit tortious interference to survive a motion to dismiss those counts.
Here, Digene’s SAC has a separate count alleging tortious interference with business relations, which Ventana has not moved to dismiss. Unlike the
Mopex
plaintiffs, however, Digene has not included a separate count alleging civil conspiracy to commit tortious interference with Digene’s business relations. Count IV specifically recites patent infringement and evasion of discovery obligations as bases for its civil conspiracy allegations.
With regard to conspiracy to infringe a patent, Digene contends that the Federal Circuit “has indeed recognized a claim for civil conspiracy for patent infringement.”
The case cited in support of this contention is
Rotating Productions Systems v. Bock Specialities, Inc.,
a nonprecedential opinion. There, the Federal Circuit did not address preemption of a state law claim by federal law. The court merely disagreed with the contention that there was no evidence supporting a jury finding of conspiracy to commit several commercial torts, including patent infringement.
Ventana points to a different nonprecedential Federal Circuit opinion where, after reversing a finding of infringement the court noted, that “Title 35 neither expressly nor implicitly authorizes additional and duplicative damages for conspiracy to infringe a patent.”
Following the precedent and rules of the Federal Circuit, however, the court will not rely on those cases in making its determination.
Other cases cited by Digene do not address the issue of federal law preemption of a state law civil conspiracy claim based on patent infringement. In
Wesley-Jessen Corp. v. Pilkington Visioncare, Inc.,
the court was addressing a foreign corporation’s motion to dismiss for lack of personal jurisdiction: it did not consider whether a claim for conspiracy to infringe a patent was preempted.
In
Shure Brothers, Inc. v. Korvettes,
Inc.,
the district court considered one defendant’s motion to dismiss a conspiracy to infringe certain patents. There, the basis of the defendant’s motion was not preemption but that “there [was] no basis in fact for the allegation of conspiracy.”
In
Kinetic Concepts, Inc. v. Bluesky Medical Corporation,
the district court
was
confronted with a preemption argument, however, the extent of that court’s analysis is as follows:
Defendants also alleged that Plaintiffs’ conspiracy claim is preempted by federal patent infringement law. Defendants have not cited any cases that are binding on this Court. The Federal Circuit has not conclusively decided the issue and federal district courts are not consistent. Therefore, the preemption claim is not dispositive of the conspiracy claim.
The only published Federal Circuit case cited to this court, by Ventana, is
International Rectifier Corp. v. Samsung Electronics Co., Ltd.
There, the Federal Circuit stated “[t]he district court’s ‘subversion by agreement’ theory is tantamount to conspiracy to infringe a patent, a
theory which has no basis in law.”
Although the Federal Circuit was not deciding the issue of federal law preemption of a state law civil conspiracy to infringe a patent claim, in making that comment, it cited the district court’s statement in
Cognitronics Imaging Systems, Inc. v. Recognition Research Inc.
that “there is no statute in the federal laws concerning patents which gives rise to a cause of action for ‘conspiracy.’ ”
Although the statement from
Cognitronics
is
dicta,
the court finds it significant that the Federal Circuit chose to quote that
dicta
in
International
Rectifier,
Federal patent law preemption of state causes of action was addressed by the Federal Circuit in
Rodime PLC v. Seagate Tech., Inc.
There, the Federal Circuit
vacated a grant of summary judgment that defendant was not liable for tortious interference with prospective economic advantage or for unfair competition. The trial court held that plaintiff had not alleged sufficient facts to support those claims and, even if sufficient facts had been alleged, the patent laws preempted those claims.
The Federal Circuit stated that “[t]he patent laws will not preempt such claims if they include additional elements not found in the federal patent law cause of action and if they are not an impermissible attempt to offer patent-like protection to subject matter addressed by federal law.”
The Federal Circuit determined that plaintiffs tortious interference and unfair competition claims included additional elements to those for a patent law cause of action of inducement to infringe and vacated the trial court’s grant of defendant’s motion for summary judgment on those claims.
Unlike the state law claims for tortious interference and unfair competition addressed in
Rodime
(which, respectively, included the requirement of proof that the acts alleged were “wrongful” and proof that “the alleged infringer’s business practice is immoral, oppressive, or the like”),
a claim for civil conspiracy under Delaware law does not require such additional proof.
There are district court decisions indicating that a claim for conspiracy to infringe is unsustainable. In
Rainville Company, Inc. v. Consupak, Inc.,
the court found that a particular claim alleged “contributory infringement and that the reference to a conspiracy has little legal significance. Evidence of conspiracy might be relevant to the issue of punitive damages for willful, malicious action in a civil action, but would not be a separate ground for recovery.”
In
ENM Company v. Transformer Manufacturers, Inc.,
plaintiff alleged patent infringement, as well as, conspiracy to offer purportedly infringing products for sale in the United States.
The court stated “there is no statute in the Federal laws concerning patents which give rise to a cause of action for ‘conspiracy’ ” and dismissed the conspiracy count.
Likewise, in
Celotex Corporation v. V.E. Power Door Corp.,
the court stated that “[pjlaintiff cites no statute creating a cause of action for conspiracy to infringe a patent, nor does plaintiff cite any authority to counter
Rainville,”
which determined evidence of conspiracy would nqt constitute a separate ground for recovery.
Consequently, the
Celotex
court stated, “[ljacking any statutory support, the count of the complaint alleging conspiracy to infringe plaintiffs patent must be dismissed for failure to state a claim.”
Other than
Mopex,
the court has not been cited any case which articulated an analysis of whether a state law civil conspiracy to infringe a patent claim is preempted by the federal patent laws. The court agrees with the analysis in
Mopex
and finds that Count IV of the SAC alleging civil conspiracy, under Delaware
law, to infringe Digene’s asserted patents is preempted by conflict with the federal patent laws.
Digene alleges that “66. Ventana and Beckman have combined and conspired for an unlawful purpose,
i.e.,
patent infringement and inducement to infringe the ’332 and ’331 patents ... with the intent to injure Digene. 67. As a direct and proximate result of the civil conspiracy, Digene has been injured by Ventana and Beckman in an amount to be proven at trial.”
Digene’s conspiracy to infringe claim in this count is duplicative of its patent law claims, in that it would allow recovery of damages for each of those claims.
If Congress had intended for patent owners to receive twice the amount of infringement damages sustained, it would have stated so. [Digene] also cannot use the possible existence of a conspiracy as a reason for extra damages, because the federal patent laws already provide extra damages for willful infringement under 35 U.S.C. § 284.
Because Digene’s conspiracy to infringe claim does not “include additional elements not found in [Digene’s] federal patent law causefs] of action”
(and Digene has raised no such argument),
the court determines that claim is preempted by federal patent law.
Count IV of the SAC also alleges that Ventana and Beckman conspired for the unlawful purpose “to evade their discovery obligations.”
The body of the SAC includes the allegations that: “Beck-man and Ventana ... conspired to further frustrate discovery of the fraudulent transaction at least until süch time as the transaction could be completed”;
“Digene concluded that Ventana had not produced responsive documents ... Digene ... wrote to Ventana pointing out the most glaring deficiencies in Ventana’s production”;
“Digene again approached Ventana regarding its glaring discovery deficiencies”;
“depositions made it crystal clear that Ventana had responsive documents ... which Ventana had simply not produced”;
“Ventana’s and its counsel’s concerted efforts to obstruct discovery are in violation of the Federal Rules of Civil Procedure and have been a proximate cause of harm to Digene”;
and “Both Ventana and Beckman failed to timely produce to Digene responsive- documents ... despite document requests and subpoenas.”
Ventana contends this does not state a cognizable claim as “it is well-settled law that an alleged violation of the Federal
Rules of Civil Procedure cannot create a private cause of action.”
Ventana points out that the Rules Enabling Act, 28 U.S.C. § 2072(b), specifically states that the Federal Rules of Civil Procedure “shall not abridge, enlarge or modify any substantive right” and that “[cjourts have uniformly interpreted this language to mean that a failure to comply with the Federal Rules cannot create a private right of action.”
Digene argues that fits civil conspiracy claim “does not arise from any perceived private right of action under the Federal Rules” but rather its claim is “that Ventana’s efforts to conceal information regarding the illegal Ventana/Beckman transaction from Digene and deprive or at least delay Digene’s ability to challenge that transaction, was a further part of its conspiracy to interfere with Digene’s business opportunities.”
The court agrees with Ventana that “Di-gene has not identified anything other than discovery obligations under the Federal Rules of Civil Procedure”
as. the basis for its claim of conspiracy “to evade ... discovery obligations.”
Because the Federal Rules of Civil Procedure do not create a private cause of action, Digene’s claim of civil conspiracy to evade discovery obligations necessarily fails.
CONCLUSION
For the reasons stated above:
It is ORDERED AND ADJUDGED that Ventana’s motion to dismiss Count IV of Digene’s Second Amended Complaint (D.I. 809) is granted.